You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

patients with interferon-based antiviral therapy

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Follow up of IFN Vs DAAs HCV SVR (IFDACS Study)

Recruiting
  • Chronic Hepatitis C Infection
    • Beijing, Beijing, China
    • +2 more
    Aug 27, 2021

    COVID-19 Infection and Its Clinical Prognosis in Chronic

    Recruiting
    • Chronic Hepatitis B
    • COVID-19 Infection
    • Beijing, Beijing, China
      Department of Hepatology Division 2, Beijing Ditan Hospital
    Mar 28, 2023

    Membranous Nephropathy Trial in Nice (Peginterferon Alfa-2A 180 MCG/ML Injectable Solution)

    Not yet recruiting
    • Membranous Nephropathy
    • Peginterferon Alfa-2A 180 MCG/ML Injectable Solution
    • Nice, France
      CHU de NICE
    Jul 4, 2023

    Sars-CoV2, Covid-19 Trial in Brazil, Canada (Peginterferon Lambda-1A, )

    Recruiting
    • Sars-CoV2
    • Covid-19
    • Peginterferon Lambda-1A
    • placebo
    • Botucatu, Brazil
    • +6 more
    Jan 17, 2022

    Chronic Hepatitis B Trial in Zhengzhou (PegIFN a- 2b)

    Completed
    • Chronic Hepatitis B
    • PegIFN α- 2b
    • Zhengzhou, Henan, China
      Henan Provincial People's Hospital
    Jul 11, 2022

    HBV pgRNA on Long-term Outcomes in Hepatitis B Patients Treated

    Not yet recruiting
    • HBV
    • HCC
    • nucleoside analogues or interferon
    • Hefei, Anhui, China
    • +9 more
    Jul 20, 2023

    Chronic Hepatitis B Trial in Zhengzhou (continuous treatment, pulse therapy)

    Recruiting
    • Chronic Hepatitis B
    • continuous treatment
    • pulse therapy
    • Zhengzhou, Henan, China
      Henan Provincial People's Hospital
    Jul 13, 2022

    HIV Trial in United States (Interferon alfa-2a, Zidovudine)

    Completed
    • HIV Infections
    • Los Angeles, California
    • +5 more
    Oct 26, 2021

    Viral Hepatitis B, Viral Hepatitis D, Cirrhosis, Liver Trial in Worldwide (REP 2139-Mg, Tenofovir Disoproxil Fumarate, Pegylated

    Available
    • Viral Hepatitis B
    • +6 more
    • REP 2139-Mg
    • +2 more
    • Vienna, Austria
    • +12 more
    Feb 1, 2023

    Hepatitis C, Cirrhosis Trial (Sofosbuvir/Velpatasvir + Ribavirin, Sofosbuvir/Velpatasvir/Voxilaprevir)

    Not yet recruiting
    • Hepatitis C
    • Cirrhosis
    • (no location specified)
    Jul 20, 2022

    CMV Viremia, CMV Trial in São Paulo (Lymphocyte infusion (ImmuneCellVir-I))

    Recruiting
    • CMV Viremia
    • CMV
    • Lymphocyte infusion (ImmuneCellVir-I)
    • São Paulo, SP, Brazil
      Hospital Israelita Albert Einstein
    Aug 21, 2023

    HIV Infection, Hepatitis C Infection Trial in Puerto Rico, United States (Nitazoxanide (NTZ), Pegylated interferon alfa-2a

    Completed
    Has Results
    • HIV Infection
    • Hepatitis C Infection
    • Nitazoxanide (NTZ)
    • +2 more
    • Birmingham, Alabama
    • +17 more
    Nov 2, 2021

    HCC, HBV Coinfection Trial in Chengdu (Tenofovir Disoproxil, Entecavir)

    Active, not recruiting
    • HCC
    • HBV Coinfection
    • Chengdu, Sichuan, China
      West China Hospital, Sichuan University
    May 23, 2022

    Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor, Symptomatic COVID-19 Infection Laboratory-Confirmed Trial in

    Recruiting
    • Hematopoietic and Lymphoid Cell Neoplasm
    • +2 more
    • Best Practice
    • +2 more
    • Buffalo, New York
      Roswell Park Cancer Institute
    Mar 1, 2022

    HCV-TARGET- Hepatitis C Therapeutic Registry and Research

    Active, not recruiting
    • Hepatitis C
      • Phoenix, Arizona
      • +59 more
      Oct 5, 2022

      Hepatitis C Trial in Tanta (Sofosbuvir, Ribavirin, Pegylated-interferon alfa-2a)

      Completed
      • Hepatitis C
      • Tanta, Egypt
      • +1 more
      Aug 1, 2020

      Depression Trial in Seoul (Mirtazapine, Supportive psychotherapy)

      Terminated
      • Depression
      • Seoul, Korea, Republic of
        SMG-SNU Boramae Medical Center
      Mar 19, 2020

      Interferon Gamma Injections in Drug-resistant Pulmonary

      Recruiting
      • Pulmonary Tuberculosis
      • Moscow, Russian Federation
        FSBI "NMIC FPI" of the Ministry of Health of Russia
      May 31, 2022

      Against HCV Based on Direct-acting Antivirals in Real-life

      Completed
      • Chronic Hepatitis C Infection
      • Seville, Andalusia, Spain
        Valme University Hospital
      Jun 22, 2022

      Study of the Use of the Drug Ingaron in Patients With COVID-19

      Completed
      • COVID-19 Respiratory Infection
      • Viral Pneumonia
      • Interferon Gamma
      • Moscow, Russian Federation
        City Clinical Hospital named after M.E. Zhadkevich Moscow City H
      May 23, 2022

      Hepatitis C Trial (Cyclosporine, Tacrolimus)

      Completed
      Has Results
      • Hepatitis C
      • (no location specified)
      Feb 14, 2022

      Predict Antiviral Therapy in Gray Zone of Chronic Hepatitis B

      Not yet recruiting
      • Hepatitis B, Chronic
      • Exposure factors
      • (no location specified)
      Sep 10, 2023

      Protease Inhibitors in Chronic Hepatitis C

      Completed
      • Chronic Hepatitis C
        • Graz, Austria
          Department of Internal Medicine, Medical University of Graz
        Jan 11, 2023

        Chronic Hepatitis c Trial in Assiut (lipid profile, fasting insulin, fibro scan)

        Recruiting
        • Chronic Hepatitis c
        • lipid profile
        • +2 more
        • Assiut, Egypt
          Assiut University hospital
        Feb 23, 2022

        Control and Elimination Within Australia of Hepatitis C From

        Active, not recruiting
        • Hepatitis C
        • +2 more
          • Burwood, New South Wales, Australia
          • +17 more
          Sep 6, 2021